Home | Welcome to Contract Pharma   
Last Updated Thursday, June 20 2013
Print RSS Feed

Breaking News

Related Searches:
Novartis To Acquire Protez Pharma

June 4, 2008
Novartis plans to acquire Protez Pharmaceuticals for as much as $400 million. Protez is a privately held biotechnology company based in Malvern, PA. Its lead drug candidate, PZ-601, is an injectable antibiotic in Phase II development for the potentia…  Read More »
Microtest Labs Doubles Microbial, Analytical Services

June 4, 2008
Microtest Laboratories has doubled its microbial identification and analytical services with the purchase of an additional MicroSeq Microbial Identification System. The MicroSeq is a DNA sequence-based system used to identify bacteria isolates that a…  Read More »
BASi

June 4, 2008
Kathleen Hodges has been appointed to the new position of vice president of quality, BASi (Bioanalytical Systems, Inc.). Ms. Hodges has corporate-wide responsibility for all matters relating to quality and regulatory issues. She has a background in q…  Read More »
Patheon Creates Japanese Subsidiary

June 3, 2008
Patheon, Inc. has established a Japanese subsidiary based in Tokyo, Japan. Patheon K.K. will operate from a new office located in the Nihonbashi district of central Tokyo and will support Patheon's business requirements in the region. Local staff wil…  Read More »
Kendle Acquires DecisionLine

June 3, 2008
Kendle has acquired DecisionLine Clinical Research Corp., a privately held, early phase CRO with a state-of-the-art medical facility in Toronto, Canada. DecisionLine specializes in Phase I studies involving the measurement of pharmacodynamic effects…  Read More »
Sartorius, WuXi AppTec Enter Viral Pact

June 3, 2008
Sartorius Stedim Biotech has entered into an agreement with WuXi AppTec, Inc., a subsidiary of WuXi PharmaTech, to work on viral clearance studies. Under this agreement, WuXi AppTec will provide the relevant viruses, materials and methodologies to Sa…  Read More »
AMRI

June 2, 2008
Dr. Philip William Small has been named managing director of European operations, AMRI. Dr. Small joined the company as director of chemistry in November 2007 to lead all scientific efforts at the Hungarian-based organization. He replaces Dr. Michael…  Read More »
Mylan Acquires Merck KGaA's Generics Businesses

June 2, 2008
Mylan, Inc. has acquired Merck KGaA's Central and Eastern Europe (CEE) generics businesses, which include operations in Poland, Hungary, Slovakia, Slovenia and the Czech Republic. Mylan exercised its option to acquire these businesses as part of a pr…  Read More »
Amgen Gets Positive Denosumab Data in Cancer Patients

June 2, 2008
Amgen reported results from three denosumab studies in cancer patients. A Phase II study of metastatic patients previously treated with IV bisphosphonates found that denosumab normalized a key marker of bone resorption at a greater rate than with IV…  Read More »
Biogen Idec

May 30, 2008
Hans Peter Hasler has been named chief operating officer, Biogen Idec. Mr. Hasler has served as executive vice president, global neurology and head of International. In his new role, he will oversee all commercial operations as well as the company&rs…  Read More »
Bilcare Expands Storage Capacity

May 30, 2008
Bilcare Global Clinical Supplies has completed the expansion of its warehouse facility in Phoenixville, PA, doubling ambient storage capacity at the facility. This expansion is part of a four-phase project to expand the warehouse and distribution are…  Read More »
Catalent Adds Warehousing, Logistics Solutions

May 30, 2008
Catalent Pharma Solutions is now offering warehousing and worldwide logistics solutions for storage, distribution, management, and the fulfillment of compliance requirements. The company's logistics services provide for short- or long-term storage in…  Read More »
BMS To Acquire Kosan Biosciences

May 29, 2008
Bristol-Myers Squibb will acquire Kosan Biosciences, a cancer therapeutics company, for approximately $190 million in cash. The acquisition adds two classes of anticancer agents to BMS's pipeline, novel Hsp90 (heat shock protein 90) inhibitors and ep…  Read More »
Lilly Submits Cymbalta sNDA for Pain

May 29, 2008
Eli Lilly and Co. has submitted a sNDA to the FDA seeking approval for a new indication for Cymbalta (duloxetine HCl) for the management of chronic pain. The submission is based on clinical trial results in chronic osteoarthritis pain of the knee and…  Read More »
Wyeth's Pneumococcal Vax Gets Fast Track

May 29, 2008
Wyeth's investigational 13-valent pneumococcal conjugate vaccine for infants and toddlers has been granted Fast Track designation by the FDA. Wyeth is seeking a pediatric indication for active immunization against invasive pneumococcal disease (IPD)…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: